Hayne Cho Park1,2, Do Hyoung Kim1,2, Ajin Cho1,2, Juhee Kim1, Kyu-Sang Yun1, Jinseog Kim3, Young-Ki Lee1,2. 1. Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea. 2. Hallym University Kidney Research Institute, Seoul, Korea. 3. Department of Bigdata and Applied Statistics, Dongguk University, Gyeongju, Korea.
Abstract
BACKGROUND: This study was performed to compare severe clinical outcome between initially asymptomatic and symptomatic infections and to identify risk factors associated with high patient mortality among initially asymptomatic patients. METHODS: In this retrospective, nationwide cohort study, we included 5621 patients who had been discharged from isolation or died from COVID-19 by 30 April 2020. The mortality rate and admission rate to intensive care unit (ICU) were compared between initially asymptomatic and symptomatic patients. We established a prediction model for patient mortality through risk factor analysis among initially asymptomatic patients. RESULTS: The prevalence of initially asymptomatic patients upon admission was 25.8%. The mortality rates were not different between groups (3.3% vs. 4.5%, p = .17). However, initially symptomatic patients were more likely to receive ICU care compared to initially asymptomatic patients (4.1% vs. 1.0%, p < .0001). The age-adjusted Charlson comorbidity index score (CCIS) was the most potent predictor for patient mortality in initially asymptomatic patients. CONCLUSIONS: The mortality risk was not determined by the initial presence of symptom among hospitalized COVID-19 patients. The CCIS was the most potent predictors for mortality. The clinicians should predict the risk of death by evaluating age and comorbidities but not the initial presence of symptom. Key messages The mortality rate was not different between initially asymptomatic and symptomatic patients. Symptomatic patients were more likely to admitted to the intensive care unit. Age and comorbidities were the potent risk factors for mortality.
BACKGROUND: This study was performed to compare severe clinical outcome between initially asymptomatic and symptomatic infections and to identify risk factors associated with high patientmortality among initially asymptomatic patients. METHODS: In this retrospective, nationwide cohort study, we included 5621 patients who had been discharged from isolation or died from COVID-19 by 30 April 2020. The mortality rate and admission rate to intensive care unit (ICU) were compared between initially asymptomatic and symptomatic patients. We established a prediction model for patientmortality through risk factor analysis among initially asymptomatic patients. RESULTS: The prevalence of initially asymptomatic patients upon admission was 25.8%. The mortality rates were not different between groups (3.3% vs. 4.5%, p = .17). However, initially symptomatic patients were more likely to receive ICU care compared to initially asymptomatic patients (4.1% vs. 1.0%, p < .0001). The age-adjusted Charlson comorbidity index score (CCIS) was the most potent predictor for patientmortality in initially asymptomatic patients. CONCLUSIONS: The mortality risk was not determined by the initial presence of symptom among hospitalized COVID-19patients. The CCIS was the most potent predictors for mortality. The clinicians should predict the risk of death by evaluating age and comorbidities but not the initial presence of symptom. Key messages The mortality rate was not different between initially asymptomatic and symptomatic patients. Symptomatic patients were more likely to admitted to the intensive care unit. Age and comorbidities were the potent risk factors for mortality.
Authors: Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner Journal: Nature Date: 2020-04-01 Impact factor: 49.962
Authors: Ki Ho Hong; Sang Won Lee; Taek Soo Kim; Hee Jae Huh; Jaehyeon Lee; So Yeon Kim; Jae Sun Park; Gab Jeong Kim; Heungsup Sung; Kyoung Ho Roh; Jae Seok Kim; Hyun Soo Kim; Seung Tae Lee; Moon Woo Seong; Namhee Ryoo; Hyukmin Lee; Kye Chul Kwon; Cheon Kwon Yoo Journal: Ann Lab Med Date: 2020-09 Impact factor: 3.464
Authors: Barbara Żółtowska; Ilona Barańska; Estera Jachowicz; Wojciech Sydor; Barbara Maziarz; Krzysztof Mydel; Anna Różańska; Barbara Wizner; Jerzy Rosiński; Magdalena Kossowska; Kaja Głomb; Jadwiga Wójkowska-Mach Journal: Int J Environ Res Public Health Date: 2022-03-29 Impact factor: 3.390